Institutional disclosure: Promise and problemsWOLK, Seth W; SINE, David M; PAULL, Douglas E et al.Journal of healthcare risk management. 2014, Vol 33, Num 3, pp 24-32, issn 1074-4797, 9 p.Article

Thoughts on signal detection in pharmacovigilanceSHAKIR, Saad A. W.Drug safety. 2007, Vol 30, Num 7, pp 603-606, issn 0114-5916, 4 p.Conference Paper

Errors in the completion of the death notification formHELENA BURGER, Elsie; VAN DER MERWE, Lize; VOLMINK, Jimmy et al.SAMJ. South African medical journal. 2007, Vol 97, Num 11, pp 1077-1081, issn 0256-9574, 5 p.Article

Effects of Author Contribution Disclosures and Numeric Limitations on Authorship TrendsMCDONALD, Robert J; NEFF, Kevin L; RETHLEFSEN, Melissa L et al.Mayo Clinic proceedings. 2010, Vol 85, Num 10, pp 920-927, issn 0025-6196, 8 p.Article

Transparency and disclosure, neutrality and balance: shared values or just shared words?GREENLAND, Sander.Journal of epidemiology and community health (1979). 2012, Vol 66, Num 11, pp 967-970, issn 0143-005X, 4 p.Article

Apport du logiciel Nadis^® dans la collecte des effets indésirables des antirétroviraux: expérience en Midi-Pyrénées = Use of Nadis^® Software to Improve Adverse Drug Reaction Reporting of Antiretroviral Drugs: Experience in South West of France (Midi-Pyrénées)POCHARD, Liselotte; HAUVILLER, Laurent; CUZIN, Lise et al.Thérapie (Paris). 2014, Vol 69, Num 2, pp 149-155, issn 0040-5957, 7 p.Article

The CLP Regulation: origin, scope and evolution : The new European Regulation 1272/2008 on Classification, labelling and packaging of substances and mixture (CLP Regulation): basic featuresDI PROSPERO FANGHELLA, Paola; CATONE, Tiziana.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 2, pp 126-131, issn 0021-2571, 6 p.Article

ÉVITER L'ÉVITABLE. Signaler les effets indésirables des soins : enjeux et limites = Notification of adverse effects of cares : benefits and limitsLa Revue Prescrire. 2008, Vol 28, Num 301, pp 864-866, issn 0247-7750, 3 p.Article

Adverse Drug Reaction Reporting by Patients: An Overview of Fifty CountriesMARGRAFF, Florence; BERTRAM, Delphine.Drug safety. 2014, Vol 37, Num 6, pp 409-419, issn 0114-5916, 11 p.Article

Assistance médicale à la procréation en France: bilan 2009 = Assisted reproductive technology in France : 2009 updateLa Revue Prescrire. 2010, Vol 30, Num 326, issn 0247-7750, p. 905Article

Écouter les patients enrichit la pharmacovigilance = Listening to patiens for improve pharmacovigilanceLa Revue Prescrire. 2008, Vol 28, Num 297, pp 506-507, issn 0247-7750, 2 p.Article

Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statementFIELD, Nigel; COHEN, Ted; CHARLETT, Andre et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 4, pp 341-352, issn 1473-3099, 12 p.Article

Notification of Abnormal Lab Test Results in an Electronic Medical Record: Do Any Safety Concerns Remain?SINGH, Hardeep; THOMAS, Eric J; SITTIG, Dean F et al.The American journal of medicine. 2010, Vol 123, Num 3, pp 238-244, issn 0002-9343, 7 p.Article

Understanding the Adverse Effects of Cosmetics: A Pilot Project in Cosmetovigilance : Phytotherapy, Food and HealthSAUTEBIN, Lidia.Drug safety. 2008, Vol 31, Num 5, pp 433-436, issn 0114-5916, 4 p.Conference Paper

Effets indésirables médicamenteux négligés en cours d'hospitalisation = Transmission of adverse drug reaction information in discharge summariesLa Revue Prescrire. 2007, Vol 27, Num 289, pp 833-833, issn 0247-7750, 1 p.Conference Paper

The effect of a workflow-based response system on hospital-wide voluntary incident reporting ratesWANG, Szu-Chang; LI, Ying-Chun; HUANG, Hung-Chi et al.International journal for quality in health care. 2013, Vol 25, Num 1, pp 35-42, issn 1353-4505, 8 p.Article

Encouraging the reporting of adverse drug reactionsANTON, Christopher.Adverse drug reaction bulletin. 2013, Num 282, pp 1087-1090, issn 0044-6394, 4 p.Article

Accounting for uncertainty about investigator bias: disclosure is informativeGREENLAND, Sander.Journal of epidemiology and community health (1979). 2009, Vol 63, Num 8, pp 593-598, issn 0143-005X, 6 p.Article

Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a spanish regionIRUJO, Marta; BEITIA, Guadalupe; BES-RASTROLLO, Maira et al.Drug safety. 2007, Vol 30, Num 11, pp 1073-1082, issn 0114-5916, 10 p.Article

Breakdown of the Consent Process at a Quaternary Medical Center: Our Full DisclosureFAIRFAX, Lindsay M; BRITTON CHRISTMAS, A; JAMES NORTON, H et al.The American surgeon. 2012, Vol 78, Num 8, pp 855-863, issn 0003-1348, 9 p.Conference Paper

Financial disclosure and clinical research : what is important to participants?HUTCHINSON, Anastasia; RUBINFELD, Abe R.Medical journal of Australia. 2008, Vol 189, Num 4, pp 207-209, issn 0025-729X, 3 p.Article

On higher ground: ethical reasoning and its relationship with error disclosureCOLE, Alexander Putnam; BLOCK, Lauren; WU, Albert W et al.BMJ quality & safety (Print). 2013, Vol 22, Num 7, pp 580-585, issn 2044-5415, 6 p.Article

From Disclosure to Transparency: The Use of Company Payment DataCHIMONAS, Susan; FROSCH, Zachary; ROTHMAN, David J et al.Archives of internal medicine (1960). 2011, Vol 171, Num 1, pp 81-86, issn 0003-9926, 6 p.Article

The National Open Disclosure Pilot : evaluation of a policy implementation initiativeIEDEMA, Rick A. M; MALLOCK, Nadine A; HEGNEY, Desley G et al.Medical journal of Australia. 2008, Vol 188, Num 7, pp 397-400, issn 0025-729X, 4 p.Article

A Comparison of the Completeness and Timeliness of Automated Electronic Laboratory Reporting and Spontaneous Reporting of Notifiable ConditionsOVERHAGE, J. Marc; GRANNIS, Shaun; MCDONALD, Clement J et al.American journal of public health (1971). 2008, Vol 98, Num 2, pp 344-350, issn 0090-0036, 7 p.Article